Clinical Trial Update: Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for NM8074 in adults with paroxysmal nocturnal hemoglobinuria who are naive to complement inhibitors. The study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: NOT_YET_RECRUITING